A citation-based method for searching scientific literature


List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Amy Damask, P Gabriel Steg, Gregory G Schwartz, Michael Szarek, Emil Hagström, Lina Badimon, M John Chapman, Catherine Boileau, Sotirios Tsimikas, Henry N Ginsberg,[...]. Circulation 2020
63
66

Deep-coverage whole genome sequences and blood lipids among 16,324 individuals.
Pradeep Natarajan, Gina M Peloso, Seyedeh Maryam Zekavat, May Montasser, Andrea Ganna, Mark Chaffin, Amit V Khera, Wei Zhou, Jonathan M Bloom, Jesse M Engreitz,[...]. Nat Commun 2018
81
66

Clinical utility of polygenic risk scores for coronary artery disease.
Derek Klarin, Pradeep Natarajan. Nat Rev Cardiol 2022
4
66

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
J L Mega, N O Stitziel, J G Smith, D I Chasman, M Caulfield, J J Devlin, F Nordio, C Hyde, C P Cannon, F Sacks,[...]. Lancet 2015
342
66

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
Jian Wang, Jacqueline S Dron, Matthew R Ban, John F Robinson, Adam D McIntyre, Maher Alazzam, Pei Jun Zhao, Allison A Dilliott, Henian Cao, Murray W Huff,[...]. Arterioscler Thromb Vasc Biol 2016
130
66

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
Philippa J Talmud, Sonia Shah, Ros Whittall, Marta Futema, Philip Howard, Jackie A Cooper, Seamus C Harrison, Kawah Li, Fotios Drenos, Frederik Karpe,[...]. Lancet 2013
370
66

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.
Pradeep Natarajan, Robin Young, Nathan O Stitziel, Sandosh Padmanabhan, Usman Baber, Roxana Mehran, Samantha Sartori, Valentin Fuster, Dermot F Reilly, Adam Butterworth,[...]. Circulation 2017
212
66

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.
Akl C Fahed, Minxian Wang, Julian R Homburger, Aniruddh P Patel, Alexander G Bick, Cynthia L Neben, Carmen Lai, Deanna Brockman, Anthony Philippakis, Patrick T Ellinor,[...]. Nat Commun 2020
76
66

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Mark Trinder, Martine Paquette, Lubomira Cermakova, Matthew R Ban, Robert A Hegele, Alexis Baass, Liam R Brunham. Circ Genom Precis Med 2020
14
66

Tutorial: a guide to performing polygenic risk score analyses.
Shing Wan Choi, Timothy Shin-Heng Mak, Paul F O'Reilly. Nat Protoc 2020
190
66

Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
Mark Trinder, Xuan Li, Maria Liza DeCastro, Luba Cermakova, Singh Sadananda, Linda M Jackson, Hawmid Azizi, G B John Mancini, Gordon A Francis, Jiri Frohlich,[...]. J Am Coll Cardiol 2019
64
66

Biological, clinical and population relevance of 95 loci for blood lipids.
Tanya M Teslovich, Kiran Musunuru, Albert V Smith, Andrew C Edmondson, Ioannis M Stylianou, Masahiro Koseki, James P Pirruccello, Samuli Ripatti, Daniel I Chasman, Cristen J Willer,[...]. Nature 2010
66

Improving reporting standards for polygenic scores in risk prediction studies.
Hannah Wand, Samuel A Lambert, Cecelia Tamburro, Michael A Iacocca, Jack W O'Sullivan, Catherine Sillari, Iftikhar J Kullo, Robb Rowley, Jacqueline S Dron, Deanna Brockman,[...]. Nature 2021
63
66


Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact.
Chiara Macchi, Nicola Ferri, Cesare R Sirtori, Alberto Corsini, Maciej Banach, Massimiliano Ruscica. Am J Pathol 2021
24
33


LocusZoom: regional visualization of genome-wide association scan results.
Randall J Pruim, Ryan P Welch, Serena Sanna, Tanya M Teslovich, Peter S Chines, Terry P Gliedt, Michael Boehnke, Gonçalo R Abecasis, Cristen J Willer. Bioinformatics 2010
33


Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data.
Arman Qamar, Robert P Giugliano, Anthony C Keech, Julia F Kuder, Sabina A Murphy, Christopher E Kurtz, Scott M Wasserman, Peter S Sever, Terje R Pedersen, Marc S Sabatine. JAMA Cardiol 2019
22
33

An Update on the Role of PCSK9 in Atherosclerosis.
Ece Yurtseven, Dilek Ural, Kemal Baysal, Lale Tokgözoğlu. J Atheroscler Thromb 2020
8
33

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.
Chiara Caselli, Serena Del Turco, Rosetta Ragusa, Valentina Lorenzoni, Michiel De Graaf, Giuseppina Basta, Arthur Scholte, Raffaele De Caterina, Danilo Neglia. Cardiovasc Diabetol 2019
22
33

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Karin Leander, Anders Mälarstig, Ferdinand M Van't Hooft, Craig Hyde, Mai-Lis Hellénius, Jason S Troutt, Robert J Konrad, John Öhrvik, Anders Hamsten, Ulf de Faire. Circulation 2016
119
33

PCSK9 induces a pro-inflammatory response in macrophages.
Chiara Ricci, Massimiliano Ruscica, Marina Camera, Laura Rossetti, Chiara Macchi, Alessandra Colciago, Ilaria Zanotti, Maria Giovanna Lupo, Maria Pia Adorni, Arrigo F G Cicero,[...]. Sci Rep 2018
98
33

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
Paul N Hopkins, Joep Defesche, Sigrid W Fouchier, Eric Bruckert, Gérald Luc, Bertrand Cariou, Barbara Sjouke, Trond P Leren, Mariko Harada-Shiba, Hiroshi Mabuchi,[...]. Circ Cardiovasc Genet 2015
71
33

PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering.
Bertrand Cariou, Zufeng Ding, Jawahar L Mehta. Atherosclerosis 2016
13
33

Context-dependence of race self-classification: Results from a highly mixed and unequal middle-income country.
Dóra Chor, Alexandre Pereira, Antonio G Pacheco, Ricardo V Santos, Maria J M Fonseca, Maria I Schmidt, Bruce B Duncan, Sandhi M Barreto, Estela M L Aquino, José G Mill,[...]. PLoS One 2019
10
33

Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Jacqueline M Anderson, Alvaro Cerda, Mario H Hirata, Alice C Rodrigues, Egidio L Dorea, Marcia M S Bernik, Marcelo C Bertolami, Andre A Faludi, Rosario D C Hirata. J Clin Lipidol 2014
21
33

Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition.
Arturo Cesaro, Vanessa Bianconi, Felice Gragnano, Elisabetta Moscarella, Fabio Fimiani, Emanuele Monda, Olga Scudiero, Giuseppe Limongelli, Matteo Pirro, Paolo Calabrò. Biofactors 2020
30
33

PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
Zhiyong Qi, Liang Hu, Jianjun Zhang, Wenlong Yang, Xin Liu, Daile Jia, Zhifeng Yao, Lin Chang, Guanxing Pan, Haoxuan Zhong,[...]. Circulation 2021
33
33

[Design and implementation of the ELSA-Brasil biobank: a prospective study in a Brazilian population].
Alexandre C Pereira, Isabela M Bensenor, Ligia M Fedeli, Cristina Castilhos, Pedro G Vidigal, Viviane Maniero, Claudia M Leite, Robercia A Pimentel, Bruce B Duncan, Jose Geraldo Mill,[...]. Rev Saude Publica 2013
12
33

Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition.
Ben M Brumpton, Lars G Fritsche, Jie Zheng, Jonas Bille Nielsen, Maria Mannila, Ida Surakka, Humaira Rasheed, Gunnhild Åberge Vie, Sarah E Graham, Maiken Elvestad Gabrielsen,[...]. Circ Genom Precis Med 2019
1
100


Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design.
Estela M L Aquino, Sandhi Maria Barreto, Isabela M Bensenor, Marilia S Carvalho, Dóra Chor, Bruce B Duncan, Paulo A Lotufo, José Geraldo Mill, Maria Del Carmen Molina, Eduardo L A Mota,[...]. Am J Epidemiol 2012
394
33

Haploview: Visualization and analysis of SNP genotype data.
Jeffrey C Barrett. Cold Spring Harb Protoc 2009
243
33

Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.
Jin Li, Leslie A Lange, Jeremy Sabourin, Qing Duan, William Valdar, Monte S Willis, Yun Li, James G Wilson, Ethan M Lange. J Hum Genet 2015
28
33

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, Pravien Abeywickrema, Vijayalakshmi Agnani, Xi Ai, Jen Baysarowich, Noel Byrne, John P Caldwell, Wonsuk Chang,[...]. Cell Chem Biol 2020
18
33

PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.
Shia T Kent, Robert S Rosenson, Christy L Avery, Yii-Der I Chen, Adolfo Correa, Steven R Cummings, L Adrienne Cupples, Mary Cushman, Daniel S Evans, Vilmundur Gudnason,[...]. Circ Cardiovasc Genet 2017
34
33

PCSK9 inhibition and inflammation: A narrative review.
Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, Cesare R Sirtori. Atherosclerosis 2019
44
33

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.
Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike,[...]. Circulation 2017
138
33

Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.
Janne Pott, Valentin Schlegel, Andrej Teren, Katrin Horn, Holger Kirsten, Christina Bluecher, Juergen Kratzsch, Markus Loeffler, Joachim Thiery, Ralph Burkhardt,[...]. Circ Genom Precis Med 2018
21
33

Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.
Shi-Jun Deng, Adekunle Alabi, Hong-Mei Gu, Ayinuer Adijiang, Shucun Qin, Da-Wei Zhang. J Lipid Res 2019
8
33

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.
Stéphane Ramin-Mangata, Matthieu Wargny, Matthieu Pichelin, Cédric Le May, Aurélie Thédrez, Valentin Blanchard, Brice Nativel, Raul D Santos, Isabela M Benseñor, Paulo A Lotufo,[...]. Atherosclerosis 2020
9
33

Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis.
Martine Paquette, Dany Gauthier, Ann Chamberland, Annik Prat, Emanuella De Lucia Rolfe, Jon J Rasmussen, Lydia Kaduka, Nabil G Seidah, Sophie Bernard, Dirk L Christensen,[...]. Clin Biochem 2020
12
33

Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
Eythór Björnsson, Guðmundur Thorgeirsson, Anna Helgadóttir, Guðmar Thorleifsson, Garðar Sveinbjörnsson, Snaedís Kristmundsdóttir, Hákon Jónsson, Aðalbjörg Jónasdóttir, Áslaug Jónasdóttir, Ásgeir Sigurðsson,[...]. Arterioscler Thromb Vasc Biol 2021
6
33


Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease.
Mark Trinder, Md Mesbah Uddin, Phoebe Finneran, Krishna G Aragam, Pradeep Natarajan. JAMA Cardiol 2020
17
33

Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Cristen J Willer, Serena Sanna, Anne U Jackson, Angelo Scuteri, Lori L Bonnycastle, Robert Clarke, Simon C Heath, Nicholas J Timpson, Samer S Najjar, Heather M Stringham,[...]. Nat Genet 2008
33

A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.
Robert A Hegele, Matthew R Ban, Neil Hsueh, Brooke A Kennedy, Henian Cao, Guang Yong Zou, Sonia Anand, Salim Yusuf, Murray W Huff, Jian Wang. Hum Mol Genet 2009
70
33

Design and user experience testing of a polygenic score report: a qualitative study of prospective users.
Deanna G Brockman, Lia Petronio, Jacqueline S Dron, Bum Chul Kwon, Trish Vosburg, Lisa Nip, Andrew Tang, Mary O'Reilly, Niall Lennon, Bang Wong,[...]. BMC Med Genomics 2021
4
33

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Stephen Burgess, Brian A Ference, James R Staley, Daniel F Freitag, Amy M Mason, Sune F Nielsen, Peter Willeit, Robin Young, Praveen Surendran, Savita Karthikeyan,[...]. JAMA Cardiol 2018
219
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.